Compare HCA Health Inc (HCA) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Altria Group Inc — how do they compare? HCA Health Inc trades at $448.9 (market cap $96.35B), while Altria Group Inc trades at $71.81 (market cap $119.25B). The key difference: Altria Group Inc is the larger of the two by market cap, and Altria Group Inc pays the higher dividend (6.22%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Altria Group Inc for 154 Days on average.
| HCA | MO | |
|---|---|---|
Market Cap | $96.35B | $119.25B |
Volume | 1,079,453 | 11,178,169 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $74.92 |
52-Week Low | $361.32 | $54.72 |
Typical Hold Time | 76 Days | 154 Days |
Enterprise Value | $146.88B | $141.46B |
Dividend Yield | 0.7% | 6.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
Altria Group (MO) trades at $71.89, up 3.61% with a bullish technical signal from moving averages. The company maintains strong profitability with 39% net margins and generates robust operating cash flow of $9.29B, supporting its 6.6% dividend yield. Recent earnings show mixed results with one beat and two misses in the last four quarters. The stock trades below analyst consensus target of $69.71 despite negative shareholder equity of -$2.24B due to high debt levels.
MO offers income investors an attractive dividend yield but faces structural challenges including declining cigarette volumes and regulatory uncertainty. Analyst consensus remains positive with 61.5% buy ratings, though concerns persist about the sustainability of dividend payments given the company's negative equity position and competitive pressures in smoke-free alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
